MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest

Area of Science:

• Biochemistry
• Neuroscience
• Cardiology

Background:

• Comatose out-of-hospital cardiac arrest (OHCA) survivors face high mortality risks from anoxic brain injury.
• MicroRNAs (miRNAs) are small, non-coding RNA molecules involved in gene silencing and show potential as stable biomarkers in bodily fluids.
• MicroRNA-9-3p (miR-9-3p) has been linked to neurological injury in trauma and subarachnoid hemorrhage.

Purpose of the Study:

• To investigate the association between miR-9-3p levels and neurological outcomes in comatose OHCA patients.
• To determine the temporal profile of miR-9-3p levels following OHCA.
• To compare the predictive value of miR-9-3p with neuron-specific enolase for neurological outcomes.

Main Methods:

• A post hoc analysis of 171 comatose OHCA patients from the target temperature management (TTM) trial.
• Patients were randomized to TTM at 33°C or 36°C.
• Plasma miR-9-3p levels were measured at admission, 28, 48, and 72 hours post-arrest.

Main Results:

• miR-9-3p levels peaked at 48 hours post-OHCA.
• No significant differences in miR-9-3p levels were observed between the 33°C and 36°C TTM groups.
• Elevated miR-9-3p levels at 48 hours were strongly associated with unfavorable neurological outcomes (OR: 2.21, P < 0.0001).
• miR-9-3p demonstrated a lower predictive accuracy for neurological outcome compared to neuron-specific enolase (AUC: 0.79 vs. 0.91).

Conclusions:

• miR-9-3p is significantly associated with neurological outcomes in OHCA survivors.
• miR-9-3p levels peak 48 hours after cardiac arrest.
• While miR-9-3p shows prognostic value, neuron-specific enolase appears to be a superior biomarker for predicting functional neurological outcome.